Augmenting glial cell-line derived neurotrophic factor signaling to treat painful neuropathies
- PMID: 24474803
- PMCID: PMC3926070
- DOI: 10.1073/pnas.1324047111
Augmenting glial cell-line derived neurotrophic factor signaling to treat painful neuropathies
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
Treating small fiber neuropathy by topical application of a small molecule modulator of ligand-induced GFRα/RET receptor signaling.Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2325-30. doi: 10.1073/pnas.1308889111. Epub 2014 Jan 21. Proc Natl Acad Sci U S A. 2014. PMID: 24449858 Free PMC article.
References
-
- Trivedi JR, Silvestri NJ, Wolfe GI. Treatment of painful peripheral neuropathy. Neurol Clin. 2013;31(2):377–403. - PubMed
-
- Lumpkin EA, Caterina MJ. Mechanisms of sensory transduction in the skin. Nature. 2007;445(7130):858–865. - PubMed
-
- Apfel SC. Neurotrophic factors and pain. Clin J Pain. 2000;16(2) Suppl:S7–S11. - PubMed
-
- Watson JJ, Allen SJ, Dawbarn D. Targeting nerve growth factor in pain: What is the therapeutic potential? BioDrugs. 2008;22(6):349–359. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
